Due to their frequency and severity, musculoskeletal diseases are, in addition to cardiovascular diseases and neoplasias, the disease group with the highest socio-economic impact.
Frequently occurring musculoskeletal diseases often affect several organ systems. The correct treatment therefore requires not only an understanding of the function of the musculoskeletal system, but also sound general internal knowledge. Know-how about the function of the immune system is also important, as disorders of the body's own defence system often lead to an outbreak.
The Department of Medicine 3 specialises in the diagnosis, treatment and research of rheumatic diseases and autoimmune diseases. This includes:
Through the development of so-called biologics, decisive therapeutic advances have been achieved in the last decade.
Clarification of unclear fever syndromes, which can conceal diseases of the immune system or hidden infections and which require a comprehensive diagnostic procedure.
Here, too, new therapeutic options are available, such as the blockade of interleukin-1.
Diagnosis and treatment of vasculitis such as granulomatous polyangilitis (GPA) (formerly Wegener's granulomatosis), eosinophilic granulomatosis with polyangilitis (EGPA) (formerly Churg-Strauss syndrome), panarteriitis nodosa, giant cell arteriitis, Takayasu arteriitis, Behcet's disease and Ormond's disease
Diagnostics, treatment and management of diseases of the bone such as osteoporosis
Diagnostics, treatment and management of IgG4 associated diseases
